BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gimeno RE, Briere DA, Seeley RJ. Leveraging the Gut to Treat Metabolic Disease. Cell Metab 2020;31:679-98. [PMID: 32187525 DOI: 10.1016/j.cmet.2020.02.014] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 8.5] [Reference Citation Analysis]
Number Citing Articles
1 Hanchard J, Capó-Vélez CM, Deusch K, Lidington D, Bolz SS. Stabilizing Cellular Barriers: Raising the Shields Against COVID-19. Front Endocrinol (Lausanne) 2020;11:583006. [PMID: 33101215 DOI: 10.3389/fendo.2020.583006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
2 Sauter ER, Heckman-Stoddard B. Metabolic Surgery and Cancer Risk: An Opportunity for Mechanistic Research. Cancers (Basel) 2021;13:3183. [PMID: 34202319 DOI: 10.3390/cancers13133183] [Reference Citation Analysis]
3 Li SZ, Zeng SL, Liu EH. Anti-obesity natural products and gut microbiota. Food Res Int 2022;151:110819. [PMID: 34980371 DOI: 10.1016/j.foodres.2021.110819] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
4 Belsham DD, Hanchard J, Bolz SS. Hope in Hopeless Times: Gearing Up to Fight the Obesity Pandemic. Endocrinology 2020;161:bqaa144. [PMID: 32894767 DOI: 10.1210/endocr/bqaa144] [Reference Citation Analysis]
5 Magkos F, Mittendorfer B. Editorial: Type 2 diabetes therapeutics: weight loss and other strategies. Curr Opin Clin Nutr Metab Care 2022;25:256-9. [PMID: 35762161 DOI: 10.1097/MCO.0000000000000839] [Reference Citation Analysis]
6 Ferraz-Bannitz R, Kashyap S, Patti ME. Bariatric Surgery: It's Not Just Incretins! J Clin Endocrinol Metab 2021:dgab694. [PMID: 34543416 DOI: 10.1210/clinem/dgab694] [Reference Citation Analysis]
7 Samms RJ, Christe ME, Collins KA, Pirro V, Droz BA, Holland AK, Friedrich JL, Wojnicki S, Konkol DL, Cosgrove R, Furber EPC, Ruan X, O'Farrell LS, Long AM, Dogra M, Willency JA, Lin Y, Ding L, Cheng CC, Cabrera O, Briere DA, Alsina-Fernandez J, Gimeno RE, Moyers JS, Coskun T, Coghlan MP, Sloop KW, Roell WC. GIPR agonism mediates weight-independent insulin sensitization by tirzepatide in obese mice. J Clin Invest 2021;131:146353. [PMID: 34003802 DOI: 10.1172/JCI146353] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
8 Le Beyec-le Bihan J, Ledoux S, Coëffier M, Le Gall M. L’intestin un organe endocrine : de la physiologie aux implications thérapeutiques en nutrition. Nutrition Clinique et Métabolisme 2022;36:75-88. [DOI: 10.1016/j.nupar.2021.12.179] [Reference Citation Analysis]
9 Beale EO, Horowitz M. Hypothesis: Bolus jejunal feeding via an enteral feeding tube simulates key features of gastric bypass to initiate similar clinical benefits. Nutrition 2021;94:111537. [PMID: 34920411 DOI: 10.1016/j.nut.2021.111537] [Reference Citation Analysis]
10 Grill HJ. A Role for GLP-1 in Treating Hyperphagia and Obesity. Endocrinology 2020;161:bqaa093. [PMID: 32516384 DOI: 10.1210/endocr/bqaa093] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 14.0] [Reference Citation Analysis]
11 Fang X, Du Z, Duan C, Zhan S, Wang T, Zhu M, Shi J, Meng J, Zhang X, Yang M, Zuo Y. Beinaglutide shows significantly beneficial effects in diabetes/obesity-induced nonalcoholic steatohepatitis in ob/ob mouse model. Life Sci 2021;270:118966. [PMID: 33482185 DOI: 10.1016/j.lfs.2020.118966] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
12 Bohm MS, Sipe LM, Pye ME, Davis MJ, Pierre JF, Makowski L. The role of obesity and bariatric surgery-induced weight loss in breast cancer. Cancer Metastasis Rev. [DOI: 10.1007/s10555-022-10050-6] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Ahn BH, Kim M, Kim SY. Brain circuits for promoting homeostatic and non-homeostatic appetites. Exp Mol Med 2022;54:349-57. [PMID: 35474340 DOI: 10.1038/s12276-022-00758-4] [Reference Citation Analysis]
14 West JA, Tsakmaki A, Ghosh SS, Parkes DG, Grønlund RV, Pedersen PJ, Maggs D, Rajagopalan H, Bewick GA. Chronic peptide-based GIP receptor inhibition exhibits modest glucose metabolic changes in mice when administered either alone or combined with GLP-1 agonism. PLoS One 2021;16:e0249239. [PMID: 33788878 DOI: 10.1371/journal.pone.0249239] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Montégut L, Lopez-Otin C, Magnan C, Kroemer G. Old Paradoxes and New Opportunities for Appetite Control in Obesity. Trends Endocrinol Metab 2021;32:264-94. [PMID: 33707095 DOI: 10.1016/j.tem.2021.02.005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
16 Berthoud HR, Albaugh VL, Neuhuber WL. Gut-brain communication and obesity: understanding functions of the vagus nerve. J Clin Invest 2021;131:143770. [PMID: 33998597 DOI: 10.1172/JCI143770] [Cited by in Crossref: 3] [Reference Citation Analysis]
17 Faramia J, Ostinelli G, Drolet-Labelle V, Picard F, Tchernof A. Metabolic adaptations after bariatric surgery: adipokines, myokines and hepatokines. Curr Opin Pharmacol 2020;52:67-74. [PMID: 32688292 DOI: 10.1016/j.coph.2020.06.005] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
18 De Bandt D, Rives-Lange C, Frigout Y, Bergerot D, Blanchard A, Le Gall M, Lacorte JM, Chevallier JM, Czernichow S, Poghosyan T, Carette C, Le Beyec J. Similar Gut Hormone Secretions Two Years After One Anastomosis Gastric Bypass and Roux-en-Y Gastric Bypass: a Pilot Study. Obes Surg 2022. [PMID: 34993850 DOI: 10.1007/s11695-021-05837-5] [Reference Citation Analysis]
19 Gautron L. The Phantom Satiation Hypothesis of Bariatric Surgery. Front Neurosci 2021;15:626085. [PMID: 33597843 DOI: 10.3389/fnins.2021.626085] [Reference Citation Analysis]
20 Albaugh VL, Kindel TL, Nissen SE, Aminian A. Cardiovascular Risk Reduction Following Metabolic and Bariatric Surgery. Surg Clin North Am 2021;101:269-94. [PMID: 33743969 DOI: 10.1016/j.suc.2020.12.012] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
21 Romaní-Pérez M, Bullich-Vilarrubias C, López-Almela I, Liébana-García R, Olivares M, Sanz Y. The Microbiota and the Gut-Brain Axis in Controlling Food Intake and Energy Homeostasis. Int J Mol Sci 2021;22:5830. [PMID: 34072450 DOI: 10.3390/ijms22115830] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
22 Beumer J, Gehart H, Clevers H. Enteroendocrine Dynamics - New Tools Reveal Hormonal Plasticity in the Gut. Endocr Rev 2020;41:bnaa018. [PMID: 32531023 DOI: 10.1210/endrev/bnaa018] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 10.0] [Reference Citation Analysis]
23 Ferguson D, Finck BN. Emerging therapeutic approaches for the treatment of NAFLD and type 2 diabetes mellitus. Nat Rev Endocrinol 2021;17:484-95. [PMID: 34131333 DOI: 10.1038/s41574-021-00507-z] [Cited by in Crossref: 35] [Cited by in F6Publishing: 26] [Article Influence: 35.0] [Reference Citation Analysis]
24 Ghidewon M, Wald HS, McKnight AD, De Jonghe BC, Breen DM, Alhadeff AL, Borner T, Grill HJ. Growth differentiation factor 15 (GDF15) and semaglutide inhibit food intake and body weight through largely distinct, additive mechanisms. Diabetes Obes Metab 2022;24:1010-20. [PMID: 35129264 DOI: 10.1111/dom.14663] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]